Format
Sort by
Items per page

Send to

Choose Destination

Selected items

Items: 20

1.

Immunization recommendations expanded for hepatitis B, HPV, pertussis vaccines.

Kuehn BM.

JAMA. 2012 Apr 4;307(13):1353-4. doi: 10.1001/jama.2012.367. No abstract available.

PMID:
22474190
3.

Evaluation of ISCOM vaccines for mucosal immunization against hepatitis B.

Pandey RS, Dixit VK.

J Drug Target. 2010 May;18(4):282-91. doi: 10.3109/10611860903450015.

PMID:
19958131
4.

Induced HBs antigenemia in healthy adults after immunization with two different hepatitis B recombinant vaccines.

Ziaee M, Saádatjoo A, Mohamadpour M, Namaei MH.

Hepat Mon. 2010 Fall;10(4):298-301. Epub 2010 Dec 1.

5.

Correlation between in vivo humoral and in vitro cellular immune responses following immunization with hepatitis B surface antigen (HBsAg) vaccines.

Leroux-Roels G, Van Hecke E, Michielsen W, Voet P, Hauser P, Pêtre J.

Vaccine. 1994 Jul;12(9):812-8.

PMID:
7975860
6.

Anamnestic immunological response profile in laboratory animals after immunization with recombinant hepatitis B vaccines of different generations.

Górska P, Michałkiewicz J, Bucholc B.

Biologicals. 2012 Nov;40(6):431-8. doi: 10.1016/j.biologicals.2012.08.001. Epub 2012 Sep 20.

PMID:
22999385
7.

A comparative trial of two surface subunit recombinant hepatitis B vaccines vs a surface and PreS subunit vaccine for immunization of healthy adults.

Eyigün CP, Yilmaz S, Gül C, Sengül A, Hacibektasoglu A, Van Thiel DH.

J Viral Hepat. 1998 Jul;5(4):265-9.

PMID:
9751013
8.

[Immunization of patients with chronic obstructive pulmonary disease with vaccines of Bubo-M and hepatitis B].

Kulakova NA, Kostinov MP, Magarshak OO, Borisova VN, Polishchuk VB.

Zh Mikrobiol Epidemiol Immunobiol. 2010 Jul-Aug;(4):27-31. Russian.

PMID:
20795382
9.

DNA vaccines for prophylactic or therapeutic immunization against hepatitis B.

Michel ML, Loirat D.

Intervirology. 2001;44(2-3):78-87. Review.

PMID:
11509869
10.

DNA vaccines for prophylactic or therapeutic immunization against hepatitis B virus.

Davis HL.

Mt Sinai J Med. 1999 Mar;66(2):84-90. Review.

PMID:
10100411
11.

New perspectives for hepatitis B vaccines and immunization.

Rapicetta M, D'Ugo E, Argentini C, Catone S, Canitano A, Giuseppetti R, Gluck R.

Vaccine. 2009 May 26;27(25-26):3271-5. doi: 10.1016/j.vaccine.2009.01.063. Epub 2009 Feb 5.

PMID:
19200835
12.

Can monovalent hepatitis A and B vaccines be replaced by a combined hepatitis A/B vaccine during the primary immunization course?

Kallinowski B, Knöll A, Lindner E, Sänger R, Stremmel W, Vollmar J, Zieger B, Jilg W.

Vaccine. 2000 Aug 15;19(1):16-22.

PMID:
10924782
13.

Decline of HBsAg antibodies after immunization with hepatitis B vaccines and after natural infection.

Braito A, Bianchini AM, Mattei C, Benci A, Marri D, Toti M.

Boll Ist Sieroter Milan. 1991-1992;70(1-2):449-51.

PMID:
1670048
14.

[Study on the non-and-low response and its determinants to recombinant yeast-derived hepatitis B vaccines among neonates after primary immunization in Shanghai].

Li J, Wu HY, Pan YJ, Cao WZ, Qian J, Ren H, Shi Y, Li YT.

Zhonghua Liu Xing Bing Xue Za Zhi. 2011 Sep;32(9):877-81. Chinese.

PMID:
22340874
15.

Anti-HBs after hepatitis B immunization with plasma-derived and recombinant DNA-derived vaccines: binding to mutant HBsAg.

Heijtink RA, van Bergen P, van Roosmalen MH, Sünnen CM, Paulij WP, Schalm SW, Osterhaus AD.

Vaccine. 2001 Jun 14;19(27):3671-80.

PMID:
11395201
17.
19.

[Revised guidelines related to booster vaccines against hepatitis B. The National Conference Committee on Immunization].

[No authors listed]

Union Med Can. 1993 Jan-Feb;122(1):47. French. No abstract available.

PMID:
8465476
20.

Efficacy of immunization with a combination of serum and recombinant hepatitis B vaccines.

Pearl KK, Ortiz AA, Pearl W.

Infect Control Hosp Epidemiol. 1993 Aug;14(8):476-8.

PMID:
8376739

Supplemental Content

Support Center